Home > News > Diversa Granted U.S. Patent
August 11th, 2003
Diversa Granted U.S. Patent
Abstract:
Diversa Corporation (Nasdaq: DVSA) today announced that it has been issued U.S. Patent No. 6,602,675, expanding its proprietary position for identifying biologically active molecules from the environment. The patent is directed to small molecule and enzyme discovery from both cultured and uncultured filamentous fungi and bacteria using high-throughput fluorescent screening. In addition to their utility for discovering novel enzyme products for agricultural and chemical applications, the technologies covered in this patent are an important part of Diversa’s small molecule discovery platform, which includes high-throughput culturing and recombinant expression for developing natural product drug candidates.
Source:
Diversa
Bookmark:
Patents/IP/Tech Transfer/Licensing
HELIOS Program Develops Complete Supply Chain for Integrating Photonics with CMOS Circuit via IC Fabrication Processes May 14th, 2013
Nanotechnology Pioneer Named 'Entrepreneur of the Year': Royal Society of Chemistry honors Chad Mirkin for commercializing innovations May 10th, 2013
Furnace accelerator startup develops anti-fogging technology May 7th, 2013
Arrowhead Receives Patent Allowance for DPC siRNA Delivery System with Peptide Backbone May 7th, 2013